Page 79 - Read Online

Maurizi et al. J Cancer Metastasis Treat 2021;7:35 https://dx.doi.org/10.20517/2394-4722.2021.74 Page 17 of 19

Nature 2009;457:102-6. DOI PubMed PMC
78. Kowanetz M, Wu X, Lee J, et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of
Ly6G+Ly6C+ granulocytes. Proc Natl Acad Sci U S A 2010;107:21248-55. DOI PubMed PMC
79. Zhao E, Wang L, Dai J, et al. Regulatory T cells in the bone marrow microenvironment in patients with prostate cancer.
Oncoimmunology 2012;1:152-61. DOI PubMed PMC
80. Monteiro AC, Leal AC, Gonçalves-Silva T, et al. T cells induce pre-metastatic osteolytic disease and help bone metastases
establishment in a mouse model of metastatic breast cancer. PLoS One 2013;8:e68171. DOI PubMed PMC
81. Celus W, Di Conza G, Oliveira AI, et al. Loss of caveolin-1 in metastasis-associated macrophages drives lung metastatic growth
through increased angiogenesis. Cell Rep 2017;21:2842-54. DOI PubMed PMC
82. Castaño Z, San Juan BP, Spiegel A, et al. IL-1β inflammatory response driven by primary breast cancer prevents metastasis-initiating
cell colonization. Nat Cell Biol 2018;20:1084-97. DOI PubMed PMC
83. Jiménez-Sánchez A, Memon D, Pourpe S, et al. Heterogeneous Tumor-Immune Microenvironments among Differentially Growing
Metastases in an Ovarian Cancer Patient. Cell 2017;170:927-938.e20. DOI PubMed PMC
84. Monteran L, Ershaid N, Sabah I, et al. Bone metastasis is associated with acquisition of mesenchymal phenotype and immune
suppression in a model of spontaneous breast cancer metastasis. Sci Rep 2020;10:13838. DOI PubMed PMC
85. Monteiro AC, Bonomo A. Dendritic cells development into osteoclast-type APCs by 4T1 breast tumor T cells milieu boost bone
consumption. Bone 2021;143:115755. DOI PubMed
86. Tomita T, Sakurai Y, Ishibashi S, Maru Y. Imbalance of Clara cell-mediated homeostatic inflammation is involved in lung
metastasis. Oncogene 2011;30:3429-39. DOI PubMed
87. Hansen MT, Forst B, Cremers N, et al. A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis,
and are targets of metastasis-inducing S100A4. Oncogene 2015;34:424-35. DOI PubMed
88. Wang L, Song L, Li J, et al. Bone sialoprotein-αvβ3 integrin axis promotes breast cancer metastasis to the bone. Cancer Sci
2019;110:3157-72. DOI PubMed PMC
89. Kwakwa KA, Sterling JA. Integrin αvβ3 signaling in tumor-induced bone disease. Cancers (Basel) 2017;9:84. DOI PubMed PMC
90. Sloan EK, Pouliot N, Stanley KL, et al. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast
cancer to bone. Breast Cancer Res 2006;8:R20. DOI PubMed PMC
91. Bachmann M, Schäfer M, Mykuliak VV, et al. Induction of ligand promiscuity of αVβ3 integrin by mechanical force. J Cell Sci
2020;133:jcs242404. DOI PubMed
92. Pang X, Gong K, Zhang X, Wu S, Cui Y, Qian BZ. Osteopontin as a multifaceted driver of bone metastasis and drug resistance.
Pharmacol Res 2019;144:235-44. DOI PubMed
93. Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC
chemokine PBSF/SDF-1. Nature 1996;382:635-8. DOI PubMed
94. Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T. Long-term hematopoietic stem cells require stromal cell-
derived factor-1 for colonizing bone marrow during ontogeny. Immunity 2003;19:257-67. DOI PubMed
95. Dar A, Goichberg P, Shinder V, et al. Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine
SDF-1 by bone marrow endothelial and stromal cells. Nat Immunol 2005;6:1038-46. DOI PubMed
96. Müller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001;410:50-6. DOI
PubMed
97. Geminder H, Sagi-Assif O, Goldberg L, et al. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived
factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001;167:4747-57. DOI PubMed
98. Sun YX, Wang J, Shelburne CE, et al. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell
Biochem 2003;89:462-73. DOI PubMed
99. Porcile C, Bajetto A, Barbero S, Pirani P, Schettini G. CXCR4 activation induces epidermal growth factor receptor transactivation in
an ovarian cancer cell line. Ann N Y Acad Sci 2004;1030:162-9. DOI PubMed
100. Sun YX, Schneider A, Jung Y, et al. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate
cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res 2005;20:318-29. DOI PubMed
101. Jung Y, Wang J, Lee E, et al. Annexin 2-CXCL12 interactions regulate metastatic cell targeting and growth in the bone marrow. Mol
Cancer Res 2015;13:197-207. DOI PubMed PMC
102. Nakamura ES, Koizumi K, Kobayashi M, et al. RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts
potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4. Clin Exp Metastasis 2006;23:9-18. DOI
PubMed
103. Moore MA. The role of chemoattraction in cancer metastases. Bioessays 2001;23:674-6. DOI PubMed
104. Zhuang X, Zhang H, Li X, et al. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.
Nat Cell Biol 2017;19:1274-85. DOI PubMed
105. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003;3:537-49.
DOI PubMed
106. Yin JJ, Selander K, Chirgwin JM, et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone
metastases development. J Clin Invest 1999;103:197-206. DOI PubMed PMC
107. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA. Modulation of transforming growth factor beta
receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 1996;97:1436-46. DOI PubMed PMC
108. Waning DL, Mohammad KS, Reiken S, et al. Excess TGF-β mediates muscle weakness associated with bone metastases in mice. Nat